A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4071-4071
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4071-4071
2002 ◽
Vol 32
(3)
◽
pp. 90-94
◽
2004 ◽
Vol 34
(6)
◽
pp. 316-322
◽
2008 ◽
Vol 38
(7)
◽
pp. 501-503
◽
2008 ◽
Vol 38
(6)
◽
pp. 432-437
◽
2012 ◽
Vol 96
(1)
◽
pp. 74-83
◽
2006 ◽
Vol 83
(1)
◽
pp. 55-62
◽